{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:13:39Z","timestamp":1761128019341,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.medmal.2003.10.003","type":"journal-article","created":{"date-parts":[[2004,1,20]],"date-time":"2004-01-20T05:18:45Z","timestamp":1074575925000},"page":"62-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["\u00c9tude sur sept ans des isolats d\u2019h\u00e9mocultures dans un service d\u2019h\u00e9matologie clinique"],"prefix":"10.1016","volume":"34","author":[{"given":"M","family":"\u00c9louennass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Foissaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Trueba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Doghmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.V","family":"Malfuson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Fagot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Mac Nab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Souleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"de Revel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Nedellec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Herv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2003.10.003_BIB1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.1994.03520150051036","article-title":"Reduction of fever and streptococcal bacteraemia in granulocytopenic patients with cancer \u2013a trial of oral penicillin V or placebo combined with pefloxacin","volume":"272","year":"1994","journal-title":"Jama"},{"key":"10.1016\/j.medmal.2003.10.003_BIB2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V","article-title":"The identification of febrile neutropenic children with neoplasic disease at low risk for bacteraemia and complications of sepsis","volume":"77","author":"Lucas","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.medmal.2003.10.003_BIB3","first-page":"34","article-title":"Prospective multicentric study of the etiology of 1051\u00a0bacteremic episodes in 782\u00a0cancer patients","volume":"1","author":"Coullioud","year":"1993","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.medmal.2003.10.003_BIB4","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0399-077X(05)81041-8","article-title":"Les infections \u00e0 cocci \u00e0 Gram positif en h\u00e9matologie et en canc\u00e9rologie","volume":"24","author":"Herbrecht","year":"1994","journal-title":"Med Mal Infect"},{"issue":"suppl 1","key":"10.1016\/j.medmal.2003.10.003_BIB5","first-page":"S35","article-title":"Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials","volume":"24","author":"Klastersky","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.medmal.2003.10.003_BIB6","first-page":"156","volume":"8","year":"1993","journal-title":"Bull Soc Fr Microbiol"},{"issue":"March","key":"10.1016\/j.medmal.2003.10.003_BIB7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"suppl D","key":"10.1016\/j.medmal.2003.10.003_BIB8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/41.suppl_4.7","article-title":"The changing pattern of infection in neutropenic patients","volume":"41","author":"Oppenheim","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2003.10.003_BIB9","first-page":"16","article-title":"Profil de r\u00e9sistance des ent\u00e9robact\u00e9ries aux b\u00eatalactamines","author":"Arlet","year":"1996","journal-title":"La lettre de l\u2019infectiologue"},{"key":"10.1016\/j.medmal.2003.10.003_BIB10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/322604","article-title":"Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519\u00a0bone marrow transplant","volume":"33","author":"Collin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2003.10.003_BIB11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteraemia in patients with cancer and neutropenic: Observations from two decades of epidemiological and clinical trials","volume":"25","author":"Elting","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2003.10.003_BIB12","unstructured":"Escande MC, Herbrecht R and the Cefpirome Study Group. Epidemiology of bacteraemia in haematology and oncology French units and comparative in vitro activity of cefpirome, cefepime and ceftazidime against isolated bacterial strains. Abstract of the Second International Symposium on Febrile Neutropenia, Bruxelles, 14-16 December 1995. Abstract 47."},{"key":"10.1016\/j.medmal.2003.10.003_BIB13","first-page":"372","article-title":"Piperacillin, betalactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of paediatric cancer patients","volume":"9","author":"Fleischhack","year":"2001","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.medmal.2003.10.003_BIB14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/00365549009027067","article-title":"A ten year survey of clinically significant blood culture isolates and antibiotic susceptibilities from adult patients with haematological diseases at a major Swedish hospital","volume":"22","author":"Fredlund","year":"1990","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.medmal.2003.10.003_BIB15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/345435","article-title":"Epidemiology and risk factors for Gram_Positive Coccal infections in neutropenia: toward a more targeted antibiotic strategy","volume":"36","author":"Cordonier","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2003.10.003_BIB16","doi-asserted-by":"crossref","unstructured":"Gonzalez-Barca E, Carratala J, Mykietiuk A, Fernandez-Sevilla A, Gudiol F. Predisposing factors and outcome of Staphylococcus aureus bacteraemia in neutropenic patients with cancer. Eur J Clin Microbiol Infect Dis 2001; 20: 117-19.","DOI":"10.1007\/PL00011241"},{"key":"10.1016\/j.medmal.2003.10.003_BIB17","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/340402","article-title":"Infections caused by viridans streptococci in patients with neutropenia","volume":"34","author":"Tunkel","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2003.10.003_BIB18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00001432-200208000-00004","article-title":"Treatment of febrile neutropenia: what is new?","volume":"15","author":"Viscoli","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.medmal.2003.10.003_BIB19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4613-1239-0_1","article-title":"Factors predisposing cancer patients to infection","volume":"79","author":"Viscoli","year":"1995","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.medmal.2003.10.003_BIB20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00001432-199712000-00002","article-title":"Virulent infections caused by alpha-haemolytic streptococci in cancer patients and their management","volume":"10","author":"Bochud","year":"1997","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.medmal.2003.10.003_BIB21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/clinids\/18.1.25","article-title":"Bacteraemia due to viridans Streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors","volume":"18","author":"Bochud","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2003.10.003_BIB22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9343(94)90009-4","article-title":"Bacteraemia due to viridians streptococci in neutropenic patients: A review","volume":"97","author":"Bochud","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.medmal.2003.10.003_BIB23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/clinids\/20.2.469","article-title":"Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis","volume":"20","author":"Donelly","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2003.10.003_BIB24","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(95)90117-5","article-title":"Viridans streptococcal bacteraemia in patients with neutropenia","volume":"345","author":"Richard","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2003.10.003_BIB25","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1128\/JCM.37.6.1876-1880.1999","article-title":"Molecular relationships and antimicrobial susceptibilities of viridians group Streptococci isolated from blood of neutropenic cancer patients","author":"Wisplinghoff","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2003.10.003_BIB26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bmt.1702739","article-title":"Aerobic bacterial and fungal infections in peripheral blood stem cell transplants","volume":"27","author":"Aksu","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.medmal.2003.10.003_BIB27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0188-4409(00)00080-1","article-title":"Microbioligical findings in febrile neutropenia","volume":"3","author":"Gaytan-Martinez","year":"2000","journal-title":"Arch Med Res"},{"key":"10.1016\/j.medmal.2003.10.003_BIB28","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0959-8049(01)00274-X","article-title":"Incidence of septicaemias and invasive mycoses in children undergoing treatment of solid tumours: a 12-year experience at a single Italian institution","volume":"37","author":"Haupts","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.medmal.2003.10.003_BIB29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/jhin.2001.1101","article-title":"Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital","volume":"50","author":"Jugo","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.medmal.2003.10.003_BIB30","first-page":"4","article-title":"La neutrop\u00e9nie f\u00e9brile","author":"Klastersky","year":"1996","journal-title":"La lettre de l\u2019infectiologue"},{"key":"10.1016\/j.medmal.2003.10.003_BIB31","first-page":"11","article-title":"Pseudomonas aeruginosa en 1997","volume":"Vol. XXXVIII- no 214","author":"Cavallo","year":"1997"},{"key":"10.1016\/j.medmal.2003.10.003_BIB32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archinte.160.4.501","article-title":"Recent experience with a Pseudomonas aeruginosa bacteremia in patients with cancer","volume":"160","author":"Chatzinikolaou","year":"2000","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.medmal.2003.10.003_BIB33","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AAC.43.4.940","article-title":"Comparison of activities of broad-spectrum beta-lactam compounds against 1128\u00a0Gram-positive cocci recently isolated in cancer treatment centres","volume":"43","author":"Diekema","year":"1999","journal-title":"Antimicrobial Agents and Chemother"},{"key":"10.1016\/j.medmal.2003.10.003_BIB34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1701303","article-title":"Vancomycin-resistant enterococcal infections in bone marrow transplant recipients","volume":"22","author":"Koc","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.medmal.2003.10.003_BIB35","first-page":"13","article-title":"Probl\u00e8mes sp\u00e9cifiques pos\u00e9s par la r\u00e9sistance aux glycopeptides chez les cocci \u00e0 Gram positif","author":"Andremont","year":"1996","journal-title":"La lettre de l\u2019infectiologue"},{"key":"10.1016\/j.medmal.2003.10.003_BIB36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0399-077X(98)80116-9","article-title":"Pseudomonas aeruginosa et infections urinaires en pratique de ville\u00a0: \u00e9tude Afrobio 1995-1996","volume":"28","author":"Cavallo","year":"1998","journal-title":"M\u00e9d Mal Infect"},{"key":"10.1016\/j.medmal.2003.10.003_BIB37","first-page":"IS12","article-title":"R\u00e9sistance aux antibiotiques chez Pseudomonas aeruginosa\u00a0: incidence de la r\u00e9sistance, nouveaux m\u00e9canismes, \u00e9pid\u00e9miologie de la r\u00e9sistance","volume":"4","author":"Bert","year":"2002","journal-title":"Antibiotiques"},{"issue":"2","key":"10.1016\/j.medmal.2003.10.003_BIB38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/AAC.39.2.445","article-title":"Piperacillin\u2013tazobactam plus amikacin vs ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer","volume":"39","author":"Cometta","year":"1995","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.medmal.2003.10.003_BIB39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0369-8114(02)00284-5","article-title":"Impact th\u00e9rapeutique des bact\u00e9ri\u00e9mies \u00e0 streptocoques et \u00e0 ent\u00e9rocoque chez des malades d\u2019h\u00e9matologie","volume":"50","author":"Ombandza-Moussa","year":"2002","journal-title":"Pathol Biol"},{"issue":"suppl D","key":"10.1016\/j.medmal.2003.10.003_BIB40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/41.suppl_4.57","article-title":"Infections du patient neutrop\u00e9nique\u00a0: revue des \u00e9tudes cliniques conduites par le groupe d\u2019\u00e9tudes des aplasies f\u00e9briles chez 608\u00a0patients neutrop\u00e9niques f\u00e9briles","volume":"41","author":"Marie","year":"1998","journal-title":"J Antimicrobial Chemother"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X03003664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X03003664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:49:09Z","timestamp":1759970949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X03003664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0399077X03003664"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2003.10.003","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tude sur sept ans des isolats d\u2019h\u00e9mocultures dans un service d\u2019h\u00e9matologie clinique","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2003.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 \u00c9ditions scientifiques et m\u00e9dicales Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}